2024年6月最新影响因子数据已经更新，欢迎查询！ 如果您对期刊系统有任何需求或者问题，欢迎反馈给我们。
 |
| 基本信息 | 登录收藏 | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字 | DIABETES & METABOLISM DIABETES METAB （此期刊被最新的JCR期刊SCIE收录） LetPub评分 7.3
50人评分
我要评分
声誉 8.7 影响力 6.3 速度 7.0 | |||||||||||||||||||||||||
| 期刊ISSN | 1262-3636 | 微信扫码收藏此期刊 | ||||||||||||||||||||||||
| E-ISSN | 1878-1780 | |||||||||||||||||||||||||
| 2023-2024最新影响因子 （数据来源于搜索引擎） | 4.6 点击查看影响因子趋势图 | |||||||||||||||||||||||||
| 实时影响因子 | 截止2024年10月29日：3.278 | |||||||||||||||||||||||||
| 2023-2024自引率 | 2.20%点击查看自引率趋势图 | |||||||||||||||||||||||||
| 五年影响因子 | 5.1 | |||||||||||||||||||||||||
| JCI期刊引文指标 | 1.35 | |||||||||||||||||||||||||
| h-index | 79 | |||||||||||||||||||||||||
| CiteScore （ 2024年最新版） |
| |||||||||||||||||||||||||
| 期刊简介 |
| |||||||||||||||||||||||||
| 期刊官方网站 | http://www.journals.elsevier.com/diabetes-and-metabolism/ | |||||||||||||||||||||||||
| 期刊投稿网址 | https://www.editorialmanager.com/DIABET | |||||||||||||||||||||||||
| 期刊语言要求 | Language Please write your text in good English (American or British usage is accepted, but not a mixture of these). Authors who feel their English language manuscript may require editing to eliminate possible grammatical or spelling errors and to conform to correct scientific English may wish to use the English Language Editing service. 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件，不仅能满足DIABETES & METABOLISM的语言要求，还能让DIABETES & METABOLISM编辑和审稿人得到更好的审稿体验，让稿件最大限度地被DIABETES & METABOLISM编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）帮助作者准备稿件，已助力全球15万+作者顺利发表论文。部分发表范例可查看：服务好评 论文致谢 。 提交文稿 | |||||||||||||||||||||||||
| 是否OA开放访问 | No | |||||||||||||||||||||||||
| 通讯方式 | MASSON EDITEUR, 21 STREET CAMILLE DESMOULINS, ISSY, MOULINEAUX CEDEX 9, FRANCE, 92789 | |||||||||||||||||||||||||
| 出版商 | Elsevier Masson | |||||||||||||||||||||||||
| 涉及的研究方向 | 医学-内分泌学与代谢 | |||||||||||||||||||||||||
| 出版国家或地区 | FRANCE | |||||||||||||||||||||||||
| 出版语言 | Multi-Language | |||||||||||||||||||||||||
| 出版周期 | Bimonthly | |||||||||||||||||||||||||
| 出版年份 | 1996 | |||||||||||||||||||||||||
| 年文章数 | 42点击查看年文章数趋势图 | |||||||||||||||||||||||||
| Gold OA文章占比 | 27.57% | |||||||||||||||||||||||||
| 研究类文章占比： 文章 ÷（文章 + 综述） | 83.33% | |||||||||||||||||||||||||
| WOS期刊SCI分区 （ 2023-2024年最新版） | WOS分区等级：1区
| |||||||||||||||||||||||||
| 中国科学院《国际期刊预警 名单（试行）》名单 | 2024年02月发布的2024版：不在预警名单中 2023年01月发布的2023版：不在预警名单中 2021年12月发布的2021版：不在预警名单中 2020年12月发布的2020版：不在预警名单中 | |||||||||||||||||||||||||
| 中国科学院SCI期刊分区 （ 2023年12月最新升级版） | 点击查看中国科学院SCI期刊分区趋势图
| |||||||||||||||||||||||||
| 中国科学院SCI期刊分区 （ 2022年12月升级版） |
| |||||||||||||||||||||||||
| 中国科学院SCI期刊分区 （ 2021年12月旧的升级版） |
| |||||||||||||||||||||||||
| SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月，原SCI撤销合并入SCIE，统称SCIE) Scopus (CiteScore) | |||||||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1262-3636%5BISSN%5D | |||||||||||||||||||||||||
| 平均审稿速度 | 网友分享经验： 较慢,6-12周 | |||||||||||||||||||||||||
| 平均录用比例 | 网友分享经验： 较易 | |||||||||||||||||||||||||
| LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍，平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）后论文在DIABETES & METABOLISM顺利发表。
快看看作者怎么说吧：服务好评 论文致谢 | |||||||||||||||||||||||||
| 期刊常用信息链接 |
| |||||||||||||||||||||||||
|
|
| |
| 中国学者近期发表的论文 | |
| 1. | Parental history of psychiatric disorders and risk of type 1 diabetes in the offspring Author: Yin, Weiyao; Persson, Martina; Sandin, Sven Journal: DIABETES & METABOLISM. 2023; Vol. 49, Issue 1, pp. -. DOI: 10.1016/j.diabet.2022.101392 PubMed DOI |
| 2. | Elevation of hemoglobin A1c increases the risk of decline in left ventricular systolic function among patients with coronary artery disease Author: Mai, Ziling; Huang, Zhidong; Li, Yuqi; Xie, Yun; Li, Huanqiang; Wang, Bo; Bai, Wei; Lai, Wenguang; Yu, Sijia; Lu, Hongyu; Han, Kedong; Chen, Xuewen; Shi, Yingming; Chen, Shiqun; Liu, Jin; Liu, Yong; Chen, Jiyan Journal: DIABETES & METABOLISM. 2023; Vol. 49, Issue 1, pp. -. DOI: 10.1016/j.diabet.2022.101411 PubMed DOI |
| 3. | Baseline and longitudinal trajectories of body-mass index and all-cause mortality among patients with type 2 diabetes Author: Yang, Zongming; Shen, Peng; Qu, Yanlin; Xu, Lisha; Li, Tiezheng; Zhu, Zhanghang; Wu, Yonghao; Yu, Luhua; Gao, Kai; Zhang, Xinhan; Yao, Xuecheng; Meng, Lin; Lin, Hongbo; Shui, Liming; Tang, Mengling; Jin, Mingjuan; Chen, Kun; Wang, Jianbing Journal: DIABETES & METABOLISM. 2023; Vol. 49, Issue 3, pp. -. DOI: 10.1016/j.diabet.2023.101426 PubMed DOI |
| 4. | Risk of cardiovascular disease, death, and renal progression in diabetes according to albuminuria and estimated glomerular filtration rate Author: Niu, Jingya; Zhang, Xiaoyun; Li, Mian; Wu, Shujing; Zheng, Ruizhi; Chen, Li; Huo, Yanan; Xu, Min; Wang, Tiange; Zhao, Zhiyun; Wang, Shuangyuan; Lin, Hong; Qin, Guijun; Yan, Li; Wan, Qin; Chen, Lulu; Shi, Lixin; Hu, Ruying; Tang, Xulei; Su, Qing; Yu, Xuefeng; Qin, Yingfen; Chen, Gang; Gao, Zhengnan; Wang, Guixia; Shen, Feixia; Luo, Zuojie; Chen, Yuhong; Zhang, Yinfei; Liu, Chao; Wang, Youmin; Wu, Shengli; Yang, Tao; Li, Qiang; Mu, Yiming; Zhao, Jiajun; Bi, Yufang; Ning, Guang; Wang, Weiqing; Lu, Jieli; Xu, Yu Journal: DIABETES & METABOLISM. 2023; Vol. 49, Issue 2, pp. -. DOI: 10.1016/j.diabet.2023.101420 PubMed DOI |
| 5. | Empagliflozin cardiovascular and renal effectiveness and safety compared to dipeptidyl peptidase-4 inhibitors across 11 countries in Europe and Asia: Results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study Author: Karasik, Avraham; Lanzinger, Stefanie; Tan, Elise Chia -Hui; Yabe, Daisuke; Kim, Dae Jung; Sheu, Wayne H. -H; Melzer-Cohen, Cheli; Holl, Reinhard W.; Ha, Kyoung Hwa; Khunti, Kamlesh; Zaccardi, Francesco; Subramanian, Anuradhaa; Nirantharakumar, Krishnarajah; Nystrom, Thomas; Niskanen, Leo; Jensen, Majken Linnemann; Hoti, Fabian; Klements, Riho; Deruaz-Luyet, Anouk; Kyaw, Moe H.; Koeneman, Lisette; Vistisen, Dorte; Carstensen, Bendix; Halvorsen, Sigrun; Langslet, Gisle; Farsani, Soulmaz Fazeli; Patorno, Elisabetta; Nunez, Julio Journal: DIABETES & METABOLISM. 2023; Vol. 49, Issue 2, pp. -. DOI: 10.1016/j.diabet.2022.101418 PubMed DOI |
| 6. | Low levels of osteocalcin, but not CTX or P1NP, are associated with nonalcoholic hepatic steatosis and steatohepatitis Author: Fang, Da; Yin, Hongli; Ji, Xinlu; Sun, Haixiang; Zhao, Xiaoyu; Bi, Yan; Gu, Tianwei Journal: DIABETES & METABOLISM. 2023; Vol. 49, Issue 2, pp. -. DOI: 10.1016/j.diabet.2022.101397 PubMed DOI |
| 7. | Coexistence of hyperuricaemia and low urinary uric acid excretion further increases risk of chronic kidney disease in type 2 diabetes Author: Ming-Yun Chen, Ai-Ping Wang, Jun-Wei Wang, Jiang-Feng Ke, Tian-Pei Yu, Lian-Xi Li, Wei-Ping Jia Journal: DIABETES & METABOLISM, 2019, Vol., , DOI:10.1016/j.diabet.2019.03.001 DOI |
| 8. | Risk of bone fracture associated with sodium–glucose cotransporter-2 inhibitor treatment: A meta-analysis of randomized controlled trials Author: L. Cheng, Y.-Y. Li, W. Hu, F. Bai, H.-R. Hao, W.-N. Yu, X.-M. Mao Journal: DIABETES & METABOLISM, 2019, Vol., , DOI:10.1016/j.diabet.2019.01.010 DOI |
| 9. | Glucagon-like peptide-1 promotes α-to-β cell transdifferentiation: How far is it from clinical application? Author: Rui Wei, Tianpei Hong Journal: DIABETES & METABOLISM, 2019, Vol., , DOI:10.1016/j.diabet.2019.01.003 DOI |
| 10. | Higher heart rates increase risk of diabetes and cardiovascular events: A prospective cohort study among Inner Mongolians Author: Tingting Wang, Wanlin Zhang, Mingzhi Zhang, Yonghong Zhang, Shaoyan Zhang Journal: DIABETES & METABOLISM, 2019, Vol., , DOI:10.1016/j.diabet.2019.01.002 DOI |
|
|
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2024 中国: LetPub上海 网站备案号：沪ICP备10217908号-1 
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
增值电信业务经营许可证：沪B2-20211595 网络文化经营许可证：沪网文[2023]2004-152号
礼翰商务信息咨询（上海）有限公司 办公地址：上海市徐汇区漕溪北路88号圣爱大厦1803室
安全保密
